αStock Quant AI
ResearchAPI
  1. Home
  2. /
  3. Research
  4. /
  5. APP

Equity Research · Thursday, October 1, 2026

APPBuyOverweight

APP Stock Analysis for October 2026

Applovin Corporation Class A Common Stock


Price at Analysis

$290.43
1Y Target$425.00+46.3%
3Y Target$675.00+132.4%

1Y Price Target

$425.00

+46.3%

vs current price

Technical Setup

RSI 35 / bearish MACD

Support context: $290.36. Resistance context: $738.01.

Valuation Snapshot

P/E 16.13x forward / P/S 15.5x trailing

Market cap $97.19B; revenue $5.48B (2025), $3.77B H1 2026.

Risk Watch

Securities fraud litigation and SEC scrutiny

Class actions alleging false statements on AI capabilities and timelines create financial liability, discovery risk, and management distraction. Prior SEC data-privacy scrutiny compounds trust deficit; adverse ruling could permanently impair multiple.

01 · Summary

Executive Summary

AppLovin has collapsed 60.6% from its $738.01 high to sit exactly on its 52-week low of $290.36, despite delivering Q1 +59% to $1.84B and Q2 +53% to $1.924B revenue growth with 83.8% adjusted EBITDA margins, ~61% net margins and ~$3.9B free cash flow. The derating was driven by a slight Q2 revenue miss, below-consensus guidance optics, a Piper Sandler downgrade to Neutral ($385 target), Edgewater channel checks warning of stalled share-of-wallet, and a securities class action alleging overstated AI model improvements and delays to its generative AI video tool that caused 12.65% and 19.6% single-day drops in July/August. At a forward P/E of ~16.1x with 40-57% 2026 sales/EPS growth expected and PEG of 0.64, the market is pricing AppLovin as a decelerating, untrustworthy gaming ad network rather than an 80%+ margin AI platform opening to self-serve e-commerce, fintech and CTV. We remain bullish, but with reduced targets versus April. The core Axon Ads Manager engine is still demonstrating pricing power — 93% higher net revenue per install despite 18% lower install volume — and sequential lumpiness from ML model upgrade timing does not equal structural share loss. With $3B cash vs $3.5B debt, 29x interest coverage, and a $7B first-year TAM from AXON self-serve, the risk/reward at the lows compensates for legal and credibility overhang. This is a washed-out compounder, not a broken thesis.

02 · Scenario Modeling

Price Targets

1Y Base Target

$425.00+46.3%

3Y Base Target

$675.00+132.4%

1-Year scenario price targets · Dashed line = current price

02 · Scenario Modeling

Scenario Analysis

Scenario1Y Target1Y Growth3Y Target3Y Growth
↑↑Hyper Bull
$550.00+89.4%$900.00+209.9%
↑Bull
$425.00+46.3%$675.00+132.4%
→Neutral
$300.00+3.3%$380.00+30.8%
↓Bear
$200.00-31.1%$180.00-38.0%
↓↓Hyper Bear
$130.00-55.2%$90.00-69.0%
↑↑Hyper Bull
1Y$550
3Y$900
1Y %+89.4%
3Y %+209.9%
↑Bull
1Y$425
3Y$675
1Y %+46.3%
3Y %+132.4%
→Neutral
1Y$300
3Y$380
1Y %+3.3%
3Y %+30.8%
↓Bear
1Y$200
3Y$180
1Y %-31.1%
3Y %-38.0%
↓↓Hyper Bear
1Y$130
3Y$90
1Y %-55.2%
3Y %-69.0%
Hyper Bull — AI video tool launches on time, self-serve delivers $7B+ spend, revenue re-accelerates to 50%+ with 85% EBITDA margins. Lawsuits dismissed, multiple re-rates to 30x EPS on $30+ 2028 EPS. Stock reclaims prior highs and compounds.
Bull — Core gaming holds, e-commerce/CTV ramp offsets deceleration to 30-35% CAGR with 80%+ margins intact. Legal overhang settles without major damages, forward P/E expands from 16x to 22-24x on restored credibility, driving 45%+ 1Y upside from washed-out low.
Neutral — Growth stabilizes at 20-25% as share plateaus and AI tool is incremental not transformative. Litigation drags, multiple stays 15-17x, stock trades range-bound around $290-350 with FCF yield supporting floor but no re-rating.
Bear — Edgewater correct: share stalled, Q4 8-9% QoQ marks sustained deceleration to teens. AI misrepresentation proven, settlement large, advertiser retention slips as Meta/Alphabet take budgets. Multiple compresses to 12x declining EPS.
Hyper Bear — Virtuous cycle breaks: model improvements stall, gaming weakness spreads, self-serve fails, revenue contracts. Fraud findings trigger massive damages, executive turnover, and permanent loss of advertiser trust leading to single-digit P/S.

03 · Fundamentals

Key Financial Metrics

Earnings Per Share (EPS)
~$18.00 forward est.
Revenue
$5.48B (2025), $3.77B H1 2026
P/E Ratio
16.13x forward
P/S Ratio
15.5x trailing
Market Cap
$97.19B
Net Income
$1.27B Q2 2026
Dividend Yield
0.00%
52-Week Low
$290.36
52-Week High
$738.01

02 · Scenario Modeling

Technical Overview

Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.

RSI (14)

35.4

Momentum Stack

1M -6.9% / 3M -48.6%

Volatility Regime

46.1% 20D vol

Regression Fit

-13.5% vs trend

Close20D MA50D MA200D MABollinger (20, 2σ)Regression channel centerline

Drawdown Curve

Distance from rolling peak, useful for regime stress and recovery speed.

-60.4%

Trend Regime

bearish

Price < 50D < 200D

Composite Signal

bearish

Bearish (-4)

Mean Reversion

bearish

-2.48 sigma

Breakout Status

bearish

Below 20D low

Range Percentile

bearish

0th pct

Volume Impulse

bullish

1.39x 20D avg

Quant Dashboard

A compact read on trend persistence, stretch, realized risk, and breakout behavior.

1M Return
-6.9%
6M Return
-27.0%
1Y Return
N/A
ATR (14)
$15.68
20D Vol
46.1%
60D Vol
65.8%
Regression R²
0.60
Price Z-Score
-2.48
52W High
$738.01
52W Low
$290.36
Range Position
0th pct
Latest Volume
6.7M

04 · Research

Micro Analysis

Fundamentals remain elite but cadence is lumpier and credibility is damaged. Pricing power and margins are intact while growth is decelerating from 50%+ toward 30-40% and management faces fraud allegations.

Axon monetization still elite

Q1 Axon Ads Manager drove 93% increase in net revenue per install despite 18% install volume decline; Q2 revenue +52.4% YoY to $1.924B with 66.4% EPS growth and 83.8% adjusted EBITDA margin. Cost of revenue fell to 11.05% in Q1, proving AI optimization leverage, not just volume growth.

Hyper-profitable cash machine

2025 revenue $5.48B +70%, H1 2026 $3.766B +56%, net income Q2 $1.267B +55%, net margins 60.8%, FCF ~$3.9B, $3B cash vs $3.5B debt with 29x interest coverage. 898 employees supporting ~$97B market cap implies extreme operating leverage.

Deceleration and stalled share signal

Edgewater's Joe Wittine channel checks conclude share-of-wallet and share-of-voice no longer consistently growing from industry-leading levels, forecasting only 8-9% QoQ Q4 growth. Q2 missed revenue expectations despite +53% and Q3 guide for +47% was deemed below whisper, triggering 20% plunge and Piper downgrade to Neutral with $385 target cut from $665.

Credibility and legal overhang

Multiple securities class actions (Robbins, Rosen, BFA, deadline Nov 16) allege material misrepresentations on AI model strength, feasibility of AI video creative tool, and 'virtuous cycle' benefits. Stock fell 12.65% July 13 and 19.66% Aug 5 on slower growth and generative AI video delays, directly contradicting prior continuous-improvement claims.

Valuation reset to reasonable

Forward P/E 16.13x, PEG 0.64, P/S ~15.5x trailing compressing to ~12x TTM on $7B+ run-rate. At $290.43, market prices ~17-18x forward EPS of ~$18 vs 57% EPS growth expected in 2026, a sharp reversal from $745 peak multiples. Zacks Rank #3 Hold reflects balanced near-term view.

04 · Research

Macro Analysis

Digital advertising is resilient but competitive and cyclical, with Meta/Alphabet dominance, higher-for-longer rates pressuring multiples, and AI-driven shift favoring measurable ROAS platforms.

Ad cycle resilience with ROAS focus

Advertiser spend rising where ROAS is proven; AppLovin citing strong advertiser returns supports budgets even as broader ad market normalizes. Performance-based DSPs gaining share vs brand spend.

Big Tech competitive moat pressure

Competition from Meta Advantage+ and Alphabet Performance Max intensifies for non-gaming budgets. AppLovin must prove Axon 2.0 efficacy outside mobile gaming against walled gardens with superior data scale.

Higher rates compress software multiples

18-month climb in rates with nominal GDP at 6.6% has pressured high-multiple software; AppLovin de-rated from >30x sales/EPS to ~16x forward EPS despite 40%+ growth, showing multiple compression risk remains if growth slows further.

AI adtech platform shift

Market rewarding AI-driven targeting and creative automation; delays in AppLovin generative AI video tool raise execution risk while peers accelerate. Successful launch would align with secular AI creative tailwind.

Gaming to commerce diversification macro

Opening AXON to self-serve expands TAM beyond gaming cyclicality into e-commerce, fintech and CTV, reducing dependence on mobile gaming install volumes which declined 18% in Q1.

05 · Growth

Untapped Revenue Opportunities

AXON self-serve beyond gaming

high

Opening closed 14-year platform to self-serve targets $7B in first-year ad spend from e-commerce, fintech and DTC brands. Replicates gaming ROAS playbook in far larger verticals with minimal incremental cost.

Generative AI video creative tool

high

Delayed AI video tool would automate creative production, lifting conversion and advertiser onboarding velocity. If delivered, restores 'virtuous cycle' narrative of better models -> better ROAS -> more spend -> more data.

CTV and web expansion

medium

MAX SSP and Axon extension to CTV/web diversifies supply and demand, capturing connected-TV performance budgets migrating from linear. Early pilots could add durable double-digit growth layer.

06 · Catalysts

Headwinds & Tailwinds

↓ Headwinds

Securities fraud litigation and SEC scrutiny

high

Class actions alleging false statements on AI capabilities and timelines create financial liability, discovery risk, and management distraction. Prior SEC data-privacy scrutiny compounds trust deficit; adverse ruling could permanently impair multiple.

Stalled market share and model lumpiness

high

Edgewater checks show SOW/SOV plateau; sequential growth dependent on timing of ML model improvements, causing volatile quarters. Q4 8-9% QoQ guide implies annualized ~35% vs 50%+ history, fueling deceleration fears.

Gaming concentration and platform risk

medium

~80% revenue from AppDiscovery DSP tied to mobile gaming; install volumes down 18%. Exposure to Apple privacy changes, Google policies, and gaming downcycles remains underappreciated.

Downgrade momentum and technical breakdown

medium

Trading at 52-week low, RSI 35.4, -4.98% vs S&P -0.25%, volume 6.7M, Piper to Neutral. Momentum funds de-risking after 1,227% run since May 2022; further estimate cuts could force capitulation.

↑ Tailwinds

Washed-out valuation vs growth

high

Forward P/E 16.13x with 40% sales / 57% EPS 2026 growth and PEG 0.64 screens as GARP. 60.8% net margins and $3.9B FCF support buybacks/deleveraging; any Q3 beat re-rates sharply from lows.

Proven advertiser ROAS and retention

high

Rising advertiser spend and 93% higher revenue per install signal strong ROAS. If retention holds, net revenue expansion funds self-serve scaling without heavy S&M.

Fortress balance sheet and leverage

medium

$3B cash, $3.5B debt, 29x coverage enables self-funded growth, M&A, and shareholder returns through cycles, rare for high-growth adtech.

07 · TL;DR

Analysis Summary

Ticker
APP
Company
Applovin Corporation Class A Common Stock
Analysis Date
2026-10-01
Price at Analysis
$290.43
Rating
Buy
1Y Price Target
$425.00
3Y Price Target
$675.00
Market Cap
$97.19B
P/E Ratio
16.13x forward

This analysis was generated on 2026-10-01 when APP was trading at $290.43. The base-case 1-year price target is $425.00 (+46.3% implied return). Scenario range: $130.00 (hyper bear) to $550.00 (hyper bull).

Disclaimer: This report is generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Past performance is not indicative of future results. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Keep Reading

More Research

CBRSSell

Cerebras Systems Inc. Class A Common Stock

2026-10-01

IOVAHold

Iovance Biotherapeutics, Inc. Common Stock

2026-09-30

FICOBuy

Fair Isaac Corporation

2026-09-30

Stock Quant AI
SupportBuilt by John Leonardo · Not financial advice.